Andrew David Wiese

Andrew David Wiese

Auto-generated profile, based on publicly available information

Andrew David Wiese

Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2022 in Psychiatry Research
Verified
Journal Article
Closed access
AWAndrew D. Wiese
Andrew D. Wiese
KDKendall N. Drummond
Kendall N. Drummond
MFMadeleine N. Fuselier
Madeleine N. Fuselier
JSJessica C Sheu
Jessica C Sheu
GLGary Liu
Gary Liu
ESEric A. Storch
Eric A. Storch

23 October 2024 in Research on Child and Adolescent Psychopathology
Verified
Journal Article
Closed access
PDF file
ETErika S. Trent
Erika S. Trent
ELElizabeth C. Lanzillo
Elizabeth C. Lanzillo
AWAndrew D. Wiese
Andrew D. Wiese
SSSamuel Spencer
Samuel Spencer
DMDean McKay
Dean McKay
ESEric A. Storch
Eric A. Storch

1 May 2024 in Bulletin of the Menninger Clinic
Verified
Journal Article
Closed access
OMOlivia J. Morris
Olivia J. Morris
AWAndrew D. Wiese
Andrew D. Wiese
CPCaitlin M. Pinciotti
Caitlin M. Pinciotti
RPRosa Pacheco
Rosa Pacheco
MMMayra C. Martinez Mallen
Mayra C. Martinez Mallen
ESEric A. Storch
Eric A. Storch

25 February 2023 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
ESEmily R. Strouphauer
Emily R. Strouphauer
OMOlivia J. Morris
Olivia J. Morris
KSKeaton J. Soileau
Keaton J. Soileau
AWAndrew D. Wiese
Andrew D. Wiese
TQTroy Quast
Troy Quast
ESEric A. Storch
Eric A. Storch

24 December 2022 in Psychiatry Research Case Reports
Verified
Journal Article
Open access
AWAndrew D. Wiese
Andrew D. Wiese
YOYasmine Omar
Yasmine Omar
ASAlan C. Swann
Alan C. Swann
WGWayne K. Goodman
Wayne K. Goodman
ESEric A. Storch
Eric A. Storch

12 March 2023 in Psychiatry Research Communications
Verified
Journal Article
Open access
JLJessica D. Leuchter
Jessica D. Leuchter
MKMinjee Kook
Minjee Kook
DGDaniel A. Geller
Daniel A. Geller
AHAlyssa G. Hertz
Alyssa G. Hertz
JGJessica Garcia
Jessica Garcia
ESEric A. Storch
Eric A. Storch
Obsessive-compulsive disorder (OCD) affects 1-2% of children and is associated with functional impairment and diminished quality of life. Several treatments are efficacious: cognitive behavioral therapy (CBT) with exposure and response prevention, serotonin reuptake inhibitor (SRI) monotherapy, and combined treatment (SRI + CBT). Expert clinician-informed practice parameters suggest that youth with mild to moderate OCD should be treated initially with CBT yet SRIs are frequently employed as the first-line intervention or in combination with psychotherapy in applied practice. Empirical data to guide SRI discontinuation in pediatric OCD are very limited. This study, Promoting OCD Wellness and Resiliency (POWER), aims to address this gap through a two phase, double-blinded, placebo-controlled, randomized controlled non-inferiority trial with the purpose of evaluating whether youth with OCD on an SRI can discontinue their medication after successful CBT augmentation and maintain wellness for a period of 24 weeks during which they receive maintenance CBT that models standard-of-care. In this paper we describe the rationale and methodological design of the POWER study.